SMDPY (Sumitomo Pharma Co) YoY EPS Growth : -72.36% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sumitomo Pharma Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Sumitomo Pharma Co's YoY EPS Growth for the quarter that ended in Sep. 2024 was -72.36%.

Sumitomo Pharma Co's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was $-0.85.

Sumitomo Pharma Co YoY EPS Growth Historical Data

The historical data trend for Sumitomo Pharma Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co YoY EPS Growth Chart

Sumitomo Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EPS Growth

Get a 7-Day Free Trial

-13.44

36.62

-8.06

-217.21

-277.19

Sumitomo Pharma Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EPS Growth	Get a 7-Day Free Trial															27.00	-318.18	-214.12	136.71	-72.36

Sumitomo Pharma Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Sumitomo Pharma Co's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (A: Mar. 2024 )
=	(Earnings per Share (Diluted) (A: Mar. 2024 )	-	Earnings per Share (Diluted) (A: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (A: Mar. 2023 ) \|
=	(-5.292	-	-1.403)	/	\| -1.403 \|
=	-277.19 %

Sumitomo Pharma Co's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EPS Growth (Q: Sep. 2024 )
=	(Earnings per Share (Diluted) (Q: Sep. 2024 )	-	Earnings per Share (Diluted) (Q: Sep. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2023 )) \|
=	(-0.848	-	-0.492)	/	\| -0.492 \|
=	-72.36 %

Sumitomo Pharma Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:SMDPY) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

DNPUF:USA 4506:Japan DPM:Germany

Address

6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.sumitomo-pharma.com

Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.